(2010) rat study showed continued improvement across 14, 30, 45, and 90-day checkpoints
Pharmaceutical companies have invested hundreds of millions of dollars in developing disease-modifying drugs, including monoclonal antibodies, inhibitors (e.g., aducanumab, donanemab, donepezil, memantine), while neurologists, psychiatrists, foundations, families, and affected individuals continue to await a transformative therapeutic breakthrough (Knopman et al., 2021)
Surgical Management and Neuromuscular Electrical Stimulation (NMES) Surgical options also exist for the treatment for OSA for patients who have failed more conservative, non-invasive treatment options
Are there foods to avoid while taking GLP-1 medications
Foster JD, Cervinski MA, Gorentla BK, Vaughan RA